The United States is a major contributor to the North American bioprocessing market, driven by strong research and development activities, growing biopharmaceutical manufacturing capacity, and increasing investments in biologics production. The expansion of biotechnology companies and the adoption of single-use technologies are further supporting market development.

According to The Insight Partners, the bioprocessing market size is projected to surge from US$ 25.35 billion in 2023 to US$ 72.55 billion by 2031. The market is estimated to register a CAGR of 14.0% during 2023–2031.

Bioprocessing Market Size, Share, Trends, Analysis, and Forecast by 2031

• Market Size: The global bioprocessing market is projected to reach US$ 72.55 billion by 2031, increasing from US$ 25.35 billion in 2023.
• Market Growth: The market is estimated to register a CAGR of 14.0% during 2023–2031, supported by rising demand for biopharmaceutical products.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00039016

• Key Trends: Single-use systems, process automation, continuous bioprocessing, and digital monitoring technologies are transforming biomanufacturing operations.
• Growth Drivers: Increasing demand for biologics, vaccines, biosimilars, and advanced therapies is accelerating the adoption of bioprocessing solutions.
• Market Opportunities: Expanding biopharmaceutical manufacturing capacity and technological advancements are creating new opportunities for equipment, consumables, and process technology providers.

Bioprocessing Market Overview

The bioprocessing market is experiencing significant growth as the pharmaceutical and biotechnology industries increasingly rely on biological processes to develop and manufacture therapeutic products. Bioprocessing involves the use of living cells, microorganisms, enzymes, and other biological materials to produce products such as monoclonal antibodies, vaccines, recombinant proteins, biosimilars, and cell and gene therapies. It encompasses upstream processing, downstream processing, and other essential activities required to manufacture biologics efficiently and consistently.

The growing demand for targeted therapies and biologic medicines is a major factor contributing to market expansion. Biopharmaceutical companies are investing in advanced manufacturing technologies to improve product quality, increase production efficiency, and meet the rising demand for complex biological products. The increasing prevalence of chronic diseases, advancements in biotechnology, and growing investments in pharmaceutical research and development are further strengthening the need for reliable bioprocessing systems.

Bioprocessing equipment and consumables play an important role in maintaining controlled manufacturing conditions. Bioreactors, filtration systems, chromatography equipment, cell culture media, and single-use bags are widely used throughout biomanufacturing workflows. These products help manufacturers manage complex biological processes while maintaining product purity, consistency, and regulatory compliance.

Key Market Drivers

The increasing demand for biologics is one of the primary drivers of the bioprocessing market. Biologic medicines are widely used to treat cancer, autoimmune disorders, infectious diseases, and other complex medical conditions. Their development and production require specialized manufacturing processes, encouraging pharmaceutical companies to invest in advanced bioprocessing equipment and technologies.

The expansion of cell and gene therapy research is another important growth factor. These therapies require specialized production environments, precise process control, and stringent quality management. As more companies advance their therapeutic candidates through clinical development, demand for flexible and scalable bioprocessing platforms is expected to increase.

Growing investments in biopharmaceutical manufacturing capacity are also supporting the market. Pharmaceutical companies are expanding production facilities and adopting advanced processing technologies to improve manufacturing flexibility and address supply chain challenges. Contract development and manufacturing organizations are contributing to this trend by providing specialized production capabilities to biotechnology companies.

Emerging Trends in the Bioprocessing Market

The adoption of single-use bioprocessing technologies is an important trend in the market. Single-use bags, tubing, connectors, and bioreactor systems can reduce cleaning and sterilization requirements between production batches. These technologies can also support faster facility changeovers and reduce the risk of cross-contamination when appropriately implemented.

Automation and digitalization are transforming bioprocessing operations. Advanced sensors, process analytical technologies, and automated control systems allow manufacturers to monitor critical parameters throughout production. These solutions can improve process consistency, support real-time decision-making, and reduce the likelihood of manufacturing errors.

Continuous bioprocessing is also attracting increasing attention. Unlike traditional batch manufacturing, continuous approaches allow certain production steps to operate continuously, potentially improving productivity and facility utilization. However, implementation requires careful process integration, validation, and regulatory oversight.

Key Players in the Bioprocessing Market

Major companies operating in the bioprocessing market include:

• Getinge AB
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Corning Inc.
• Bio-Rad Laboratories Inc.
• Merck KGaA
• 3M Co.
• Eppendorf SE
• Repligen Corp.
• Entegris Inc.
• Agilent Technologies Inc.
• Cytiva US LLC

These companies provide a range of bioprocessing equipment, consumables, filtration solutions, analytical instruments, and manufacturing technologies. Market participants focus on product innovation, capacity expansion, strategic partnerships, and acquisitions to strengthen their positions. The development of scalable, efficient, and flexible solutions remains an important competitive priority as biopharmaceutical manufacturing requirements evolve.

Bioprocessing Market Regional Analysis

North America: North America represents a major market for bioprocessing technologies due to its established biotechnology sector, advanced research infrastructure, and substantial investment in biologic drug development. The presence of leading pharmaceutical manufacturers and technology providers supports the adoption of innovative processing equipment and consumables.

Europe: Europe benefits from a strong pharmaceutical manufacturing base, established biotechnology research capabilities, and continued investment in biologics production. Regulatory emphasis on product quality and manufacturing consistency supports demand for advanced bioprocessing technologies.

Asia Pacific: Asia Pacific offers substantial growth opportunities as countries expand pharmaceutical manufacturing infrastructure and invest in biotechnology research. Increasing demand for biologics, the development of contract manufacturing capabilities, and government support for life sciences industries are contributing to regional growth.

South and Central America: Improvements in pharmaceutical manufacturing capabilities and increasing interest in biotechnology research are creating opportunities for bioprocessing suppliers. Greater investment in healthcare infrastructure may further support adoption.

Middle East and Africa: Investments in healthcare infrastructure, pharmaceutical manufacturing, and biotechnology capabilities are expected to create opportunities for market development. However, differences in manufacturing infrastructure, technical expertise, and investment capacity may influence adoption across individual countries.

Future Outlook

The bioprocessing market is expected to benefit from continued advancements in biotechnology, growing demand for biologic medicines, and increasing investment in manufacturing infrastructure. Single-use systems, automation, continuous processing, and digital monitoring are likely to remain important areas of innovation. Companies that develop scalable, reliable, and cost-efficient solutions will be well positioned to address evolving biopharmaceutical manufacturing requirements through 2031.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
Email: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish